Speaker

Tapan Maniar

Chief Medical Officer, Oblenio Bio

Tapan Maniar, Chief Medical Officer at Oblenio Bio, spoke at 2nd T-Cell Engager for Autoimmune Disease Summit (Boston, United States of America, 27–29 Oct 2026) in the session “Panel Discussion: Translating First-Wave Autoimmune T-Cell Engager Clinical Data into Safer, More Effective Next-Generation Therapies”.

Conferences: 1
Keynotes: 0
Upcoming: 0

Past appearances

2nd T-Cell Engager for Autoimmune Disease Summit
27–29 Oct 2026Boston, United States of America
- PanelPanel Discussion: Translating First-Wave Autoimmune T-Cell Engager Clinical Data into Safer, More Effective Next-Generation TherapiesWith Mike Liao, Jeffrey Jones
- SpeakerTranslating Dual-Targeting T-Cell Engager Strategies into Clinical Success Through Biomarker-Driven Development & Early Human Insights

More speakers at 2nd T-Cell Engager for Autoimmune Disease Summit

Mike Jones
Search & Evaluation Lead, GI & Inflammation, Strategy & Portfolio Development, Takeda Pharmaceutical
Giovanni Abbadessa
Chief Medical Officer, ModeX Therapeutics
Patrick Baeuerle
Chief Scientific Advisor & Chairman of Scientific Advisory Board, Cullinan Therapeutics, Inc.
Xingfeng Bao
Senior Vice President & Head of Research, GV20 Therapeutics LLC
Alexander Boches
Chief Business Officer, NovalGen
Elaine Chen
Senior Scientist, Translational Biology, Rondo Therapeutics

See all 19 speakers on the event page

This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Tapan Maniar, and it lists only the talks, sessions and presentations named in those programmes.

Is this you? Claim this profile — every request is read by a person before anything is linked.

To ask for a correction or for this profile to be removed, email [email protected].